ArticleCancer chemotherapy and pharmacology2014

Novel LHRH-receptor-targeted cytolytic peptide, EP-100: first-in-human phase I study in patients with advanced LHRH-receptor-expressing solid tumors.

Kelly K Curtis et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.